Table 3 Drug related problems among ambulatory patients with type 2 diabetes on follow up from July to December 2018 at HFSUH, Harar, Ethiopia
DRPs | Frequency | Percentage |
|---|---|---|
Number of patients with DRP | ||
Single DRP | 59 | 62.1 |
Double DRPs | 36 | 37.9 |
Total | 95 | 100 |
Types of DRPs | ||
Dosage too low | 46 | 36.2 |
Metformin + glibenclamide | 10 | 7.9 |
Meftormin + basal insulin | 13 | 10.2 |
Metformin | 18 | 14.2 |
Basal insulin | 5 | 3.9 |
Ineffective drug | 25 | 19.7 |
Basal insulin alone | 8 | 6.3 |
Metformin alone | 1 | 0.8 |
Glibenclamide | 3 | 2.4 |
Metformin + basal insulin | 5 | 3.9 |
Metformin + glibenclamide | 6 | 4.7 |
Basal insulin + glibenclamide | 2 | 1.6 |
Unnecessary drug therapy | 25 | 19.7 |
Basal insulin as unnecessary | 10 | 7.9 |
Glibenclamide as unnecessary | 15 | 11.8 |
Need for additional drug therapy | 17 | 13.4 |
Taking metformin alone | 12 | 9.4 |
Taking metformin and glibenclamide | 3 | 2.4 |
Taking glibenclamide | 2 | 1.6 |
Adverse drug reaction | 12 | 9.4 |
Metformin | 2 | 1.6 |
Glibenclamide | 6 | 4.7 |
Basal insulin | 4 | 3.1 |
Dosage too high | 2 | 1.6 |
Basal insulin | 2 | 1.6 |
Total DRPs | 127 | 100 |